Krishna Institute of Medical Sciences Limited has informed the Exchange regarding a press release dated May 12, 2025, titled "Press Release on the audited (Standalone & Consolidated) financial results of the Companyfor the quarter and financial year ended 31st March 2025.".
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KIMS Hospitals reported strong Q4 FY25 results with consolidated total revenue of INR 801 Cr, up 25.7% year-on-year and 1.4% quarter-on-quarter. EBITDA stood at INR 203 Cr (up 24.4% YoY) with margins at 25.3%, while profit after tax jumped to INR 106 Cr from INR 72 Cr in Q4 FY24. For the full year FY25, total revenue grew 22% YoY to INR 3,067 Cr, EBITDA rose 24.7% to INR 815 Cr with margins expanding to 26.6% from 26.0%, and PAT grew to INR 415 Cr from INR 336 Cr in FY24. Consolidated EPS for FY25 was INR 9.6, a 24% jump over the previous year. Operationally, Average Revenue Per Occupied Bed (ARPOB) grew 22.7% YoY in FY25 with inpatient and outpatient volumes rising 11.6% and 14.1% respectively. The company began operations at Thane in April 2025 and plans to open two new units in Bangalore in the first half of FY26, expanding its 19-hospital, 5,500+ bed network.
Strong double-digit revenue and profit growth, along with margin expansion, signals healthy business momentum. Expansion into new geographies like Kerala, Thane and Bangalore could drive future growth, though investors should watch for execution risks and any impact on margins from new unit ramp-ups.